The NFL held a press conference on Tuesday during its fall league meeting where officials expressed satisfaction with the Philadelphia Eagles’ approach to quarterback Jalen Hurts’ care regarding his blood clots. They also took the opportunity to push back against reports that mischaracterized the situation.
However, things took a turn later that evening when the NFL Players Association issued a statement that contrasted sharply with the league’s claims. The statement criticized the NFL for jumping to conclusions about the handling of Hurts’ situation and revealed that the league had informed the union it would not be conducting a review of the care he received.
This raises some interesting questions about the NFL’s position—how can the league confidently defend the Eagles’ actions when, you know, a thorough review hasn’t even taken place? So, instead of resolving the concerns surrounding Hurts’ health issues, new doubts have emerged.
Dr. Allen Sills, the NFL’s chief medical officer, voiced his confidence in the Eagles’ medical staff. He described their approach as cautious, patient-focused, and appropriately measured throughout the process. He emphasized that in the last decade, the number of players diagnosed with deep vein thrombosis, like in Hurts’ case, has been quite low.
Sills noted that every incident, including Hurts’, undergoes careful scrutiny. He mentioned how, in Hurts’ case specifically, there was a heightened sense of vigilance and conservatism in diagnosing conditions that might have gone unnoticed in others who aren’t athletes.
Despite Sills expressing trust in the decision-making that took place during Hurts’ care, the lack of a formal review seems to cast a shadow over the league’s confident assurances. That’s puzzling, isn’t it?
Jeff Miller, the NFL’s executive vice president, further underlined that they were well-informed about the circumstances of Hurts’ treatment by engaging both the Eagles’ staff and independent medical professionals. This represents a strong defense of the Eagles and their medical team, although the timing of the NFLPA statement created a disconnect.
According to the NFLPA, they are “not aware of any NFL investigation” into the care provided to Hurts. This directly opposes the NFL’s previous statements, claiming that no review was planned and raising eyebrows about how the league can be so firm in its conclusions without a comprehensive investigation.
The NFLPA accused the league of speculating, urging that before any definitive statements can be made, a complete investigation needs to occur to clarify the situations that unfolded. They stressed that establishing the facts is crucial for the ongoing protection and care of players.
